The silencing of SMAD4 further activates the extracellular signal‐regulated kinase/ Myelocytomatosis viral oncogene homolog (ERK/c‐Myc) signaling cascade, which plays a pivotal role in the molecular mechanism of drug resistance in NSCLC.[40]. Here, SMAD4 is linked to non-small cell lung carcinoma.